Literature DB >> 18314010

The transmembrane topology of Batten disease protein CLN3 determined by consensus computational prediction constrained by experimental data.

Timothy Nugent1, Sara E Mole, David T Jones.   

Abstract

The CLN3 gene encodes an integral membrane protein of unknown function. Mutations in CLN3 can cause juvenile neuronal ceroid lipofuscinosis, or Batten disease, an inherited neurodegenerative lysosomal storage disease affecting children. Here, we report a topological study of the CLN3 protein using bioinformatic approaches constrained by experimental data. Our results suggest that CLN3 has a six transmembrane helix topology with cytoplasmic N and C-termini, three large lumenal loops, one of which may contain an amphipathic helix, and one large cytoplasmic loop. Surprisingly, varied topological predictions were made using different subsets of orthologous sequences, highlighting the challenges still remaining for bioinformatics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314010     DOI: 10.1016/j.febslet.2008.02.049

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Clinical trials in rare disease: challenges and opportunities.

Authors:  Erika F Augustine; Heather R Adams; Jonathan W Mink
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

2.  Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  J M Kwon; H Adams; P G Rothberg; E F Augustine; F J Marshall; E A Deblieck; A Vierhile; C A Beck; N J Newhouse; J Cialone; E Levy; D Ramirez-Montealegre; L S Dure; K R Rose; J W Mink
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

3.  The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking.

Authors:  Susan L Cotman; John F Staropoli
Journal:  Clin Lipidol       Date:  2012-02

4.  Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.

Authors:  Cristy A Ku; Sarah Hull; Gavin Arno; Ajoy Vincent; Keren Carss; Robert Kayton; Douglas Weeks; Glenn W Anderson; Ryan Geraets; Camille Parker; David A Pearce; Michel Michaelides; Robert E MacLaren; Anthony G Robson; Graham E Holder; Elise Heon; F Lucy Raymond; Anthony T Moore; Andrew R Webster; Mark E Pennesi
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

5.  S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.

Authors:  Sandra Codlin; Sara E Mole
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

6.  Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).

Authors:  Megan E Bosch; Amy Aldrich; Rachel Fallet; Jessica Odvody; Maria Burkovetskaya; Kaitlyn Schuberth; Julie A Fitzgerald; Kevin D Foust; Tammy Kielian
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

7.  The fission yeast model for the lysosomal storage disorder Batten disease predicts disease severity caused by mutations in CLN3.

Authors:  Rebecca L Haines; Sandra Codlin; Sara E Mole
Journal:  Dis Model Mech       Date:  2008-12-22       Impact factor: 5.758

8.  Novel CLN3 mutation causing autophagic vacuolar myopathy.

Authors:  Andrea Cortese; Arianna Tucci; Giovanni Piccolo; Carlo A Galimberti; Pietro Fratta; Enrico Marchioni; Gianpiero Grampa; Cristina Cereda; Gaetano Grieco; Ivana Ricca; Alan Pittman; Patrizia Ciscato; Laura Napoli; Valeria Lucchini; Michela Ripolone; Raffaella Violano; Gigliola Fagiolari; Sara E Mole; John Hardy; Arrigo Moglia; Maurizio Moggio
Journal:  Neurology       Date:  2014-05-14       Impact factor: 9.910

9.  Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.

Authors:  Xiao Zhang; Dan Zhang; Jennifer A Thompson; Shang-Chih Chen; Zhiqin Huang; Luke Jennings; Terri L McLaren; Tina M Lamey; John N De Roach; Fred K Chen; Samuel McLenachan
Journal:  Mol Genet Genomic Med       Date:  2021-01-26       Impact factor: 2.183

10.  Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.

Authors:  Jessica L Centa; Francine M Jodelka; Anthony J Hinrich; Tyler B Johnson; Joseph Ochaba; Michaela Jackson; Dominik M Duelli; Jill M Weimer; Frank Rigo; Michelle L Hastings
Journal:  Nat Med       Date:  2020-07-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.